BamSEC and AlphaSense Join Forces
Learn More

Akebia Therapeutics Inc.

NASDAQ: AKBA    
Share price (1/8/25): $1.79    
Market cap (1/8/25): $391 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 22 pages Second Amended and Restated Bylaws of Akebia Therapeutics, Inc. Section 1 - Stockholders
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment of Ninth Restated Certificate of Incorporation of Akebia Therapeutics, Inc
12/34/56
EX-3.2
from 8-K 20 pages Amended and Restated Bylaws of Akebia Therapeutics, Inc. Section 1 - Stockholders
12/34/56
EX-3.1
from 8-K 7 pages Akebia Therapeutics, Inc. Ninth Amended and Restated Certificate of Incorporation
12/34/56
EX-3.5
from S-1/A 3 pages Certificate of Amendment of Eighth Amended and Restated Certificate of Incorporation of Akebia Therapeutics, Inc
12/34/56
EX-3.2
from S-1/A 20 pages Amended and Restated Bylaws of Akebia Therapeutics, Inc. Section 1 - Stockholders
12/34/56
EX-3.1
from S-1/A 8 pages Akebia Therapeutics, Inc. Ninth Amended and Restated Certificate of Incorporation
12/34/56
EX-3.4
from S-1 8 pages Akebia Therapeutics, Inc. Bylaws Adopted as of April 3, 2007 Amended Pursuant to That Certain Joint Action by Unanimous Written Consent of the Board of Directors and the Stockholders of Akebia Therapeutics, Inc., Dated as of January 22, 2008: Akebia Therapeutics, Inc. Bylaws
12/34/56
EX-3.3
from S-1 34 pages Eighth Amended and Restated Certificate of Incorporation of Akebia Therapeutics, Inc
12/34/56
EX-3
from DRS 8 pages Akebia Therapeutics, Inc. Bylaws Adopted as of April 3, 2007 Amended Pursuant to That Certain Joint Action by Unanimous Written Consent of the Board of Directors and the Stockholders of Akebia Therapeutics, Inc., Dated as of January 22, 2008: Akebia Therapeutics, Inc. Bylaws
12/34/56
EX-3
from DRS 34 pages Eighth Amended and Restated Certificate of Incorporation of Akebia Therapeutics, Inc
12/34/56